These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 18544310)

  • 21. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia: a review.
    Girolami B; Girolami A
    Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of heparin-induced thrombocytopenia.
    Kouides PA; Fricke W
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
    Chong BH; Eisbacher M
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-induced thrombocytopenia.
    Chong BH; Chong JJ
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of a new, rapid, automated immunoassay for the detection of anti-platelet factor 4/heparin complex antibodies.
    Davidson SJ; Ortel TL; Smith LJ
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):340-4. PubMed ID: 21415710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia.
    Greinacher A; Fürll B; Selleng S
    Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
    Mattioli AV
    Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
    Janatpour KA; Gosselin RC; Dager WE; Lee A; Owings JT; Zhou J; Wun T
    Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.